Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

Clinical trial NCT00236093 · COMPLETED

Trial details

NCT number: NCT00236093
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain Cancer Sickle Cell Anemia Severe Burns

Start date: 2006-10-01
Primary completion: 2006-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.